David Wilson
David Wilson
University of New South Wales, Burnet Institute, Bill and Melinda Gates Foundation, Queensland
Verified email at
Cited by
Cited by
Tuberculosis: commentary on a reemergent killer
BR Bloom, CJL Murray
Science 257 (5073), 1055-1064, 1992
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta‐analysis
FM Islam, J Wu, J Jansson, DP Wilson
HIV medicine 13 (8), 453-468, 2012
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
BR Bavinton, AN Pinto, N Phanuphak, B Grinsztejn, GP Prestage, ...
The lancet HIV 5 (8), e438-e447, 2018
Relation between HIV viral load and infectiousness: a model-based analysis
DP Wilson, MG Law, AE Grulich, DA Cooper, JM Kaldor
The Lancet 372 (9635), 314-320, 2008
Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART
F Jin, J Jansson, M Law, GP Prestage, I Zablotska, JCG Imrie, SC Kippax, ...
Aids 24 (6), 907-913, 2010
Elasticity of the red cell membrane and its relation to hemolytic disorders: an optical tweezers study
J Sleep, D Wilson, R Simmons, W Gratzer
Biophysical journal 77 (6), 3085-3095, 1999
“Know your epidemic, know your response”: a useful approach, if we get it right
D Wilson, DT Halperin
The Lancet 372 (9637), 423-426, 2008
HIV prevalence in China: integration of surveillance data and a systematic review
L Zhang, EPF Chow, J Jing, X Zhuang, X Li, M He, H Sun, X Li, ...
The Lancet infectious diseases 13 (11), 955-963, 2013
Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies:“STROBE-RDS” statement
RG White, AJ Hakim, MJ Salganik, MW Spiller, LG Johnston, L Kerr, ...
Journal of clinical epidemiology 68 (12), 1463-1471, 2015
Type III secretion a la Chlamydia
J Peters, DP Wilson, G Myers, P Timms, PM Bavoil
Trends in microbiology 15 (6), 241-251, 2007
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand
N Ford, D Wilson, GC Chaves, M Lotrowska, K Kijtiwatchakul
Aids 21, S21-S29, 2007
The cost-effectiveness of harm reduction
DP Wilson, B Donald, AJ Shattock, D Wilson, N Fraser-Hurt
International Journal of Drug Policy 26, S5-S11, 2015
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action
FA Akala, I Semini
World Bank Publications, 2010
Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men
DP Wilson, A Hoare, DG Regan, MG Law
Sexual health 6 (1), 19-33, 2009
Planification de la gestion de la sécurité sanitaire de l’assainissement: gestion des risques étape par étape pour des systèmes d’assainissement gérés en toute sécurité
World Health Organization
World Health Organization, 2023
Using complexity and network concepts to inform healthcare knowledge translation
A Kitson, A Brook, G Harvey, Z Jordan, R Marshall, R O’Shea, D Wilson
International journal of health policy and management 7 (3), 231, 2018
HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention
DP Wilson
PLoS medicine 9 (7), e1001231, 2012
The system can't perform the operation now. Try again later.
Articles 1–20